Registration for a live webinar on 'Innovative Vaccines and Viral Pathogenesis: Insights from Recent Monkeypox (Mpox) Research' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Outline
- Respiratory pathogens
- Respiratory viruses in children in Vietnam
- Henle’s (Koch’s) postulates
- Rivers’ postulates
- Fredricks and Relman
- Human metapneumovirus
- Human coronavirus NL63
- Human coronavirus HKU1
- Rhinovirus C
- Human bocavirus
- KI and WU polyoma viruses
- SARS paramyxovirus
- SARS coronavirus
- New influenza viruses in humans
- Discovery in the respiratory tract
- Other aspects of discovery in general
- 454 sequencing method
- Illumina sequencing method
- Microarrays
- Basic local alignment search tool (BLAST)
- Eureka!
- Acknowledgements
Topics Covered
- Pathogen discovery in the respiratory tract
- An overview of recently discovered viruses in the respiratory tract
- Techniques for directed and agnostic viral detection
- From nucleic acid sequence to proof of disease causation
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
van Doorn, H.R. (2013, July 11). Pathogen discovery in the respiratory tract [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved November 23, 2024, from https://doi.org/10.69645/GDFH8655.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. H. Rogier van Doorn has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Pathogen discovery in the respiratory tract
Published on July 11, 2013
24 min
A selection of talks on Infectious Diseases
Transcript
Please wait while the transcript is being prepared...
0:00
Hello. My name is H.
Rogier Van Doorn,
I work as a Clinical
Virologist at
the Oxford University
Clinical Research Unit
in Ho Chi Minh City, Vietnam.
My areas of interest
are influenza and
foot and mouth disease
in pathogen discovery.
In this talk, I will discuss
pathogen discovery in
the respiratory tract.
0:17
I will briefly talk about
respiratory infections in
general and the pathogens
associated with them.
I will discuss the
rules for establishing
a link between a
pathogen or a sequence
and disease as they have been
applied since the
late 19th century
and the required
adaptations to make
them applicable in a
molecular era too.
I will give an overview of
pathogens exclusively viruses
that have been discovered using
molecular techniques
in this millennium.
I will discuss the
peculiarities of
respiratory tract samples
and the consequences for
pathogen discovery attempts and
discuss some of the technologies
that are being used
for pathogen detection
or discovery in
various settings.
I advise you to also
have a look at the
Henry Stewart talks
from Ron Fouchier on
emerging respiratory viruses and
from Ian Lipkin on novel approaches to viral
diagnosis as these inevitably overlap with mine.
1:06
Acute respiratory infections are
the most frequently
occurring illness
in all age groups globally.
Infection is usually limited
to the upper
respiratory tract and
presents as a mild and
self-limiting illness
like the common cold.
A small percentage
can progress to
a lower respiratory
tract infection
as bronchiolitis or pneumonia.
Annually, 450 million cases
of pneumonia are recorded,
of whom 4.2 million die.
Young children and the elderly
are at an increased risk,
especially in
developing countries.
The most important
etiologic agents of severe,
lower respiratory illnesses
are bacteria like
Streptococcus pneumoniae and Haemophilus
influenzae type B and viruses,
as respiratory syncytial
virus and influenza virus.
Bacteria are the main
cause of pneumonia,
especially in adults and
generally have a higher
case fatality rate.
Viruses are the
predominant cause of
bronchiolitis and episodic
wheeze exacerbation
in children and of
uncomplicated upper respiratory
tract infections in general.
Apart from the usual suspects as
pneumococcus, Haemophilus
influenza viruses,
and RSV, there is a myriad of
pathogens that have
been associated
with respiratory infections.
Among these are mostly
endemic human pathogens,
to a lesser extent
environmental or
zoonotic pathogens
and pathogens that are
exclusively related to
certain geographic areas
or to severely compromise
of the immune system.
Although many viruses have
been added to the list of
common endemic pathogens
in the last few years,
there may still be
endemic pathogens
that we haven't discovered yet.
On top of that,
novel viruses are
continuously emerging in the
animal reservoir and may
cause anything from isolated
sporadic infections
to pandemics of severe disease.
This slide shows the etiology